MeSH D012559 - schizophrenia
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D019967:Schizophrenia spectrum and other psychotic disorders
D012559:Â
Schizophrenia
D000090663:Treatment-resistant schizophrenia
0 Companies
0 Drugs
Success rate
D012560:Catatonic schizophrenia
0 Companies
0 Drugs
Success rate
D012562:Disorganized schizophrenia
0 Companies
0 Drugs
Success rate
D012753:Shared paranoid disorder
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| A.H. Robins Company | Reserpine | Reserpine |  | 1982-01-01 |  |  |
| Abbott Biotherapeutics | Chlorpromazine | Chlorpromazine |  | 1982-01-01 |  |  |
| AbbVie | Hydrochlorothiazide, Deserpidine | Oreticyl |  | 1982-01-01 |  |  |
| Cariprazine | Vraylar | 2028-12-16 | 2015-09-17 | $3,132 M | Q4/23-Q3/24 | |
| Able Laboratories | Prochlorperazine | Prochlorperazine |  | 2001-07-11 |  |  |
| Accord Healthcare | Aripiprazole | Aripiprazole |  | 2016-12-07 |  |  |
| Aripiprazole | Aripiprazole Accord |  | 2015-11-15 |  |  | |
| Clonazepam | Clonazepam |  | 2005-05-02 |  |  | |
| Clozapine | Clozapine |  | 2015-11-25 |  |  | |
| Lurasidone | Lurasidone |  | 2019-01-03 |  |  | |
| Quetiapine | Quetiapine |  | 2016-11-01 |  |  | |
| ACRAF | Lurasidone | Latuda |  | 2014-03-21 |  |  |
| Ajanta Pharma | Aripiprazole | Aripiprazole |  | 2016-09-12 |  |  |
| Olanzapine | Olanzapine |  | 2017-05-30 |  |  | |
| Risperidone | Risperidone |  | 2011-08-24 |  |  | |
| Fluphenazine | Fluphenazine |  | 2023-01-05 |  |  | |
| Brexpiprazole | Brexpiprazole |  | 2023-02-03 |  |  | |
| Carbamazepine | Carbamazepine |  | 2023-03-24 |  |  | |
| Prochlorperazine | Prochlorperazine |  | 2024-05-09 |  |  | |
| Paliperidone | Paliperidone |  | 2024-06-26 |  |  | |
| Alembic Pharmaceuticals | Aripiprazole | Aripiprazole |  | 2015-04-28 |  |  |
| Asenapine | Asenapine |  | 2020-12-10 |  |  | |
| Clonazepam | Clonazepam |  | 2019-06-28 |  |  | |
| Lurasidone | Lurasidone |  | 2021-05-13 |  |  | |
| Quetiapine | Quetiapine |  | 2014-10-28 |  |  | |
| Chlorpromazine | Chlorpromazine |  | 2023-07-18 |  |  | |
| Fluphenazine | Fluphenazine |  | 2024-07-23 |  |  | |
| Paliperidone | Paliperidone |  | 2024-09-26 |  |  | |
| Alexza Pharmaceuticals | Loxapine | Adasuve | 2022-05-20 | 2012-12-21 |  |  |
| Alkem Laboratories | Aripiprazole | Aripiprazole |  | 2019-02-21 |  |  |
| Olanzapine | Olanzapine |  | 2015-10-20 |  |  | |
| Quetiapine | Quetiapine |  | 2013-02-12 |  |  | |
| Lurasidone | Lurasidone |  | 2022-12-13 |  |  | |
| Brexpiprazole | Brexpiprazole |  | 2023-11-28 |  |  |
1
2
3
4
5
6
...
19
>
Clinical Trials
Historical Success Rate
Phase 1
83%73/88
Phase 2
68%89/130
Phase 3
58%132/228
Approved: 50Overall Success rate: 33%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
...
13
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use